BIOQUAL Declares Dividend

Rhea-AI Summary

BIOQUAL has declared a $1.00 per share dividend for shareholders of record on October 6, 2022, payable on October 27, 2022. This marks the twenty-first dividend issued by the company.

While the announcement reflects the company's ongoing commitment to returning value to shareholders, the press release also includes forward-looking statements that highlight risks related to securing government contracts, managing costs, and the availability of resources.

Positive

• Declared a $1.00 dividend per share, providing income for shareholders.
• This marks the twenty-first dividend, indicating a history of returning value to investors.

Negative

• Risks associated with the ability to extend current government contracts and secure new ones.
• Concerns about demand for animal models and employee availability affecting operations.

ROCKVILLE, Md.--(BUSINESS WIRE)-- BIOQUAL’s Board of Directors has declared a dividend of $1.00 per share for shareholders of record on October 6, 2022, payable on October 27, 2022. This is the twenty-first dividend declared by BIOQUAL.

Statements herein that are not descriptions of historical facts are forward-looking and subject to risks and uncertainties. The forward-looking statements are neither promises nor guarantees, and you should not place undue reliance on these forward-looking statements because they involve known and unknown risks, uncertainties, and other factors, many of which are beyond the Company’s control and which could cause actual results to differ materially from those expressed or implied by these forward-looking statements, including risks relating to the ability to continue to extend current government contracts; the Company’s ability to obtain new government or commercial contracts; continued demand for the use of animal models in scientific research; the Company’s ability to obtain sufficient numbers of animal models; the availability of adequate numbers of employees; the Company’s ability to perform under its contracts in accordance with the requirements of the contracts; the actual costs incurred in performing the Company’s contracts and its ability to manage its costs, including its capital expenditures; dependence on third parties; future capital needs; the ability to fund its capital needs through the use of its cash on hand and line of credit; and the future availability and cost of financing/capital sources to the Company.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220927006077/en/

Mark G. Lewis, Ph.D., CEO (240-404-7654)

Source: BIOQUAL

FAQ

What is the dividend amount declared by BIOQUAL?

BIOQUAL has declared a dividend of $1.00 per share.

When will the dividend be paid to shareholders?

The dividend will be payable on October 27, 2022.

Who is eligible for the BIOQUAL dividend?

Shareholders of record as of October 6, 2022, are eligible for the dividend.

How many dividends has BIOQUAL declared?

This is the twenty-first dividend declared by BIOQUAL.

What risks does BIOQUAL mention regarding future operations?

BIOQUAL mentions risks related to securing contracts, managing costs, and resource availability.